Consensus EPS · Q2 2026
$4.77
Consensus revenue · Q2 2026
$3.7B
Analysts
10
Expected report
Jul 30, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 10 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $3.7B | $3.7B | $3.7B |
| EPS | $4.68 | $4.77 | $4.82 |
| EBITDA | $619.1M | $622.5M | $627.5M |
| EBIT | $445.8M | $448.2M | $451.8M |
| Net income | $389.6M | $396.2M | $415.2M |
- Revenue$3.7B
- EPS$4.77
- EBITDA$622.5M
- EBIT$448.2M
- Net income$396.2M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $3.5B | $3.5B | +0.8% | $4.25 | $4.11 | +3.4% |
- Q1 2026+0.8%+3.4%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Labcorp Holdings (LH) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
- Low
- $300.00
- Consensus
- $311.33
- Median
- $300.00
- High
- $334.00
- Current
- $281.46
- Upside
- +10.6%
Upside calculated vs most recent trading price of $281.46.
Analyst ratings
Consensus: Buy — based on 35 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 13, 2026 | Baird | maintain | Outperform | Outperform |
| Jul 13, 2026 | B of A Securities | maintain | Buy | Buy |
| Apr 8, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Feb 24, 2026 | Piper Sandler | maintain | Neutral | Neutral |
| Feb 18, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Feb 18, 2026 | Baird | maintain | Outperform | Outperform |
| Feb 6, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Nov 7, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Oct 29, 2025 | UBS | maintain | Buy | Buy |
| Oct 17, 2025 | UBS | maintain | Buy | Buy |
- Jul 13, 2026BairdOutperform
- Jul 13, 2026B of A SecuritiesBuy
- Apr 8, 2026Evercore ISI GroupOutperform
- Feb 24, 2026Piper SandlerNeutral
- Feb 18, 2026JP MorganOverweight
- Feb 18, 2026BairdOutperform
- Feb 6, 2026JP MorganOverweight
- Nov 7, 2025JP MorganOverweight
- Oct 29, 2025UBSBuy
- Oct 17, 2025UBSBuy
Frequently asked questions
Labcorp Holdings (LH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.50% TTM
- Dividend Profile1.02% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.